[Federal Register Volume 72, Number 82 (Monday, April 30, 2007)]
[Notices]
[Page 21298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-8131]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances Notice of Application

    Pursuant to Sec.  1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 1, 2007, Organichem 
Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made 
application by letter to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of Oxymorphone (9652), a basic 
class of controlled substance listed in schedule II.
    The company plans on manufacturing the listed controlled substance 
in bulk for sale to its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such a substance may file comments or 
objections to the issuance of the proposed registration pursuant to 21 
CFR 1301.33(a).
    Any such written comments or objections being sent via regular mail 
should be addressed, in quintuplicate, to the Drug Enforcement 
Administration, Office of Diversion Control, Attention: DEA Federal 
Register Representative (ODL), Washington, DC 20537, or any being sent 
via express mail should be sent to Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
2401 Jefferson-Davis Highway, Alexandria, Virginia 22301; and must be 
filed no later than June 29, 2007.

    Dated: April 17, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement Administration.
 [FR Doc. E7-8131 Filed 4-27-07; 8:45 am]
BILLING CODE 4410-09-P